U.S. Pharmaceutical and Medical Manufacturers: Supply Chain Trends and Canadian Cross-Border Efficiencies

The good news for U.S. pharmaceutical and medical device manufacturers is the increasingly global marketplace and its surge in new customers.  But the not so good news is the accompanying deluge of regulatory and compliance issues.  The volume of regulatory measures can be overwhelming, even when products are traveling between the U.S. and Canada.  American manufacturers face myriad regulations as they try to expand their customer bases to reach the Canadian market. 


This new white paper from Purolator International, “U.S. Pharmaceutical and Medical Device Manufacturers:  Supply Chain Trends and Canadian Cross Border Efficiencies,” details current trends in that industry, and offers recommendations for efficient border crossings, and a more effective supply chain.  

You must have javascript enabled in your browser to receive the whitepaper successfully